Psychoeducation program for individuals who have attempted suicide
Effectiveness of the First French Psychoeducational Program for Suicidal Behavior : a Randomized Controlled Trial
This study is testing whether a psychoeducation program can help people aged 18 to 65 who have recently attempted suicide by reducing the chances of them trying again compared to a relaxation program.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03185026 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the effectiveness of a psychoeducational program (PEPSUI) compared to a relaxation program in reducing the rate of suicide re-attempts over a two-year follow-up period. Participants, aged 18 to 65, who have attempted suicide in the past year will be enrolled and assessed for various outcomes, including severity of suicidal ideation, treatment adherence, and overall quality of life. The study will track changes at multiple time points post-intervention to determine the long-term benefits of psychoeducation in this high-risk population.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have a current suicidal behavior disorder and have attempted suicide within the past year.
Not a fit: Patients with organic mental disorders, schizophrenia, or those unable to comply with the study's visit requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce the rate of suicide re-attempts and improve overall mental health outcomes for individuals at risk.
How similar studies have performed: Previous studies have shown that psychoeducational programs can effectively prevent relapse in various mental disorders, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 18 and 65 years * Having a current suicidal behaviour disorder according to DSM-5 (APA, 2013), i.e. history of suicidal attempt in the past year * Able to speak, read and understand French. * Able to give written informed consent * Having signed informed consent * Must belong to social safety system Exclusion Criteria: * Having a current or past diagnosis of an organic mental disorder * Having a lifetime history of schizophrenia * Having a mental retardation * Planned longer stay outside the region that prevents compliance with the visit plan * Deprived of liberty Subject (by judicial or administrative decision) * Protected by law (guardianship) * Current exclusion period in relation to another protocol
Where this trial is running
Montpellier
- Uh Montpellier — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Déborah DUCASSE, MD
- Email: d-ducasse@chu-montpellier.fr
- Phone: 00 33 4 67 33 82 89
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.